Reticulohistiocytoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Reticulohistiocytoma

What is the definition of Reticulohistiocytoma?
Reticulohistiocytoma (RH) is a rare benign lesion of the soft tissue. It belongs to a group of disorders called non-Langerhans cell histiocytosis and is a type of reticulohistiocytosis, all of which are types of histiocytosis. Histiocytosis is a condition in which there is rapid production (proliferation) of histiocytes (immune cells) in the skin or soft tissues. The stimulus that causes the immune system to react in RH is currently not well understood. RH present as a yellow to reddish-brown smooth surfaced, firm nodule or lesion on the trunk and/or extremities of the body. Historically, RH has been found in young adults, with a slightly higher incidence in males.
What are the alternative names for Reticulohistiocytoma?
  • Reticulohistiocytoma
  • Solitary histiocytoma
  • Solitary reticulohistiocytosis
Who are the top Reticulohistiocytoma Local Doctors?
Elite in Reticulohistiocytoma
Hematology | Oncology
Elite in Reticulohistiocytoma
Hematology | Oncology

ETSU Pediatrics- St. Jude's Clinic

400 N State Of Franklin Rd, Fl 1, 
Johnson City, TN 
Languages Spoken:
English
Offers Telehealth

. Dr. Nichols is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, and Bone Marrow Transplant. Dr. Nichols is board certified in American Board Of Pediatrics.

Elite in Reticulohistiocytoma
Elite in Reticulohistiocytoma

The Children's Hospital At Montefiore

3415 Bainbridge Avenue, 
Bronx, NY 
Languages Spoken:
English

Melissa Wasserstein is a Pediatrics provider practicing medicine in Bronx, New York. Dr. Wasserstein is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, Reticulohistiocytoma, and Splenomegaly.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Reticulohistiocytoma
Hematology | Oncology
Elite in Reticulohistiocytoma
Hematology | Oncology

Office

1102 Bates Ave Ste 750, 
Houston, TX 
Languages Spoken:
English

Carl Allen is a Hematologist and an Oncologist practicing medicine in Houston, Texas. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Transplant.

What are the latest Reticulohistiocytoma Clinical Trials?
Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis

Summary: This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that is growing, spreading, or getting worse (progressive), has come back (relapsed) after previous treatment, or does not respond to therapy (refractory). Langerhans cell histiocytosis is a type of disease that occurs when the body makes too ma...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C

Background: Niemann-Pick type C (NPC) disease is a rare, progressive neurodegenerative disease that affects mainly the brain, liver, and spleen but also other parts of the body. There is no cure for NPC, and symptoms only get worse over time. Symptoms can include seizures, difficulty moving or talking, or dementia. But symptoms can vary among different people with the disease. Some may have seizures, while ot...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center